Here are five GLP-1 programs worth knowing about in 2026, ranked with the strongest overall option first
Semaglutide (Wegovy, Ozempic, Rybelsus): risk of non-arteritic anterior ischaemic optic neuropathy (NAION)
The Food and Drug Administrations approval of Wegovy, Novo Nordisks latest obesity drug, for adolescents aged 12 years and older opens up a highly-anticipated tool in the fight against childhood obesity, but some doctors warn the sought-after medication isnt a magic bullet
How long does prior authorization take
Smoking, using mouthwash with alcohol, or consuming hot beverages shortly before dosing can all affect the oral mucosa
GLP-1 receptor agonists like Ozempic and Wegovy can cause nausea, vomiting, diarrhea, stomach pain, and constipation